- Execution rate: 1 share - 1 voting right
- Planned Meeting time: 29/4/2026, specific time will be announced
- Meeting venue: to be announced
- Meeting agenda:
+ Aproval of the report by the Management Board
+ Approval of report by the Board of Directors on governance and activities of the BOD and its members
+ Approval of the report by the Supervisory Board on business results, activities of the BOD, the CEO
+ Approval of 2025 audited financial statements
+ Approval of proposal for 2025 remuneration payment to the BOD, SB and 2026 plan
+ Approval of proposal for selecting an audit company for 2026
+ Approval of proposal for 2025 after-tax profit distribution
+ Approval of transactions with related parties
+ Other issues within the authority of the General Meeting (if any)
Coordination details and procedures for corporate action processing for holders of the above securities between VSDC, the Securities registering institution and depository members are specified in the Guideline on corporate action processing for securities holders at VSDC.
Nam Ha Pharmaceutical Joint Stock Company and the parties involved in the process of preparing the dossier, documents of corporate action processing are fully responsible before the law for the legality, accuracy, truthfulness and completeness of the dossier; Institutions and individuals participating in the confirmation of records and documents shall be legally responsible within the scope related to such records and documents as prescribed in Clause 1, Article 11a of the Securities Law No. 54/2019/QH14 dated 26/11/2019, supplemented by Clause 4, Article 1 of Law No. 56/2024/QH15 dated 29/11/2024.